Related Experiment Videos
Naloxone reduces release of creatine kinase in the isolated ischemic rat heart
Insights
Naloxone and propranolol significantly reduced creatine kinase (CK) release during heart ischemia in rats. Combining these drugs offered an additive protective effect against myocardial damage.
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Background:
- Myocardial ischemia can lead to cellular damage and release of intracellular enzymes like creatine kinase (CK).
- Understanding protective agents against ischemia-induced cardiac injury is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the effects of naloxone and propranolol, individually and in combination, on the release of creatine kinase (CK) from isolated ischemic rat hearts.
- To determine the dose-dependent effect of naloxone on CK release during myocardial ischemia.
Main Methods:
- Isolated rat hearts were subjected to myocardial ischemia.
- Perfusion with varying concentrations of naloxone (1.1 and 3.6 mmole/L) and propranolol (7 mumole/L) was performed.
- The release of creatine kinase (CK) into the perfusate was measured to assess cardiac damage.
Main Results:
- Naloxone significantly reduced CK release in a dose-dependent manner during myocardial ischemia.
- Propranolol also demonstrated a reduction in CK release.
- The combined administration of naloxone and propranolol resulted in a further, additive reduction of CK release.
Conclusions:
- Both naloxone and propranolol exhibit protective effects against ischemia-induced cardiac damage by reducing creatine kinase release.
- The combination of naloxone and propranolol provides an additive benefit, suggesting a synergistic or complementary mechanism of action in protecting the ischemic heart.
Abstract:
The effects of naloxone, propranolol, or both on the release of creatine kinase (CK) from the isolated ischemic rat heart were studied. Naloxone at concentrations of 1.1 and 3.6 mmole liter-1 in the perfusate at a rate of 1-2 ml min-1 reduced the release of CK from the isolated ischemic rat heart during myocardial ischemia in a dose-dependent manner. Propranolol at a concentration of 7 mumole liter-1 in the perfusate also reduced the release of CK. Addition of naloxone (1.1 mmole liter-1) to propranolol further reduced the release of CK. The effect of the joint administration of the two drugs seemed to be additive.